222 related articles for article (PubMed ID: 24522810)
1. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.
Liu X; Yao N; Qian J; Huang H
Med Oncol; 2014 Mar; 31(3):878. PubMed ID: 24522810
[TBL] [Abstract][Full Text] [Related]
2. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
Yang X; Sun Y; Li H; Shao Y; Zhao D; Yu W; Fu J
Oncotarget; 2017 Apr; 8(16):26154-26168. PubMed ID: 28412731
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin.
Shi Y; Liu X; Sun Y; Wu D; Qiu A; Cheng H; Wu C; Wang X
J Mol Histol; 2015 Apr; 46(2):221-31. PubMed ID: 25758127
[TBL] [Abstract][Full Text] [Related]
4. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.
Ye L; Sun PH; Malik MF; Mason MD; Jiang WG
J Cancer Res Clin Oncol; 2014 Jun; 140(6):957-67. PubMed ID: 24667935
[TBL] [Abstract][Full Text] [Related]
5. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
[TBL] [Abstract][Full Text] [Related]
6. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
Tang D; Xu S; Zhang Q; Zhao W
Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
[TBL] [Abstract][Full Text] [Related]
7. CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis.
Dai F; Xuan Y; Jin JJ; Yu S; Long ZW; Cai H; Liu XW; Zhou Y; Wang YN; Chen Z; Huang H
Oncotarget; 2017 Apr; 8(17):28736-28749. PubMed ID: 28404932
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
9. Downregulated expression of the cyclase-associated protein 1 (CAP1) reduces migration in esophageal squamous cell carcinoma.
Li M; Yang X; Shi H; Ren H; Chen X; Zhang S; Zhu J; Zhang J
Jpn J Clin Oncol; 2013 Sep; 43(9):856-64. PubMed ID: 23904342
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
11. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation.
Hua M; Yan S; Deng Y; Xi Q; Liu R; Yang S; Liu J; Tang C; Wang Y; Zhong J
Int J Mol Med; 2015 Apr; 35(4):941-9. PubMed ID: 25652936
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
15. Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer.
Bergqvist M; Elebro K; Sandsveden M; Borgquist S; Rosendahl AH
Breast Cancer Res; 2020 Jun; 22(1):67. PubMed ID: 32560703
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion.
Zeng J; Li X; Liang L; Duan H; Xie S; Wang C
J Cancer Res Clin Oncol; 2022 Jan; 148(1):137-153. PubMed ID: 34636991
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
[TBL] [Abstract][Full Text] [Related]
19. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
